Vesalius Therapeutics’ AI-based technology finds novel targets and intervention points for subgroups of patients within a common disease. A small molecule that Vesalius has been developing for a novel Parkinson’s disease target is now headed to GSK, which has licensed global rights. The post GSK Wagers $80M on a Tech Platform and Parkinson’s Drug from…
Our goal should be to make lymphedema a preventable aspect of cancer survivorship or at a minimum, manageable, rather than a debilitating aftereffect that diminishes patients’ quality of life. The post Revolutionizing Breast Cancer Survivorship Care: Early Detection and Prevention of Lymphedema appeared first on MedCity News.
In the 2024 election, seven out of 10 states passed ballot measures protecting abortion rights. But the effects won’t be seen immediately, experts say. The post 7 States Passed Abortion Rights Ballot Measures. But Changes Won’t be Like a “Light Switch,” Experts Say appeared first on MedCity News.
Right to repair would undermine the FDA’s regulations and introduce unnecessary risk into the healthcare industry, threatening the high-quality care that doctors provide patients. The post Don’t Erode Medical Device Trust with Right to Repair appeared first on MedCity News.
Providing proactive and preventive health-focused living among younger, less affluent senior populations — and extending this into value-based care — just makes sense. The post Bundling Boomer Housing with On-site Primary Care and Wellness-Focused Living: It Just Makes Sense appeared first on MedCity News.
To ramp up its food-as-medicine support, NationsBenefits has acquired Good Measures, a company that offers coaching and personalized food prescriptions. The post NationsBenefits Acquires Good Measures to Advance Food-as-Medicine Offerings appeared first on MedCity News.
Halozyme’s offer comes as Evotec deals with several business setbacks and a languishing stock price. Earlier this year, Evotec implemented a cost-saving corporate restructuring. The post Halozyme Makes Unsolicited €2B Takeover Bid for Drug R&D Services Firm Evotec appeared first on MedCity News.
To overcome challenges and ensure that RPM reaches its full potential, both providers and payers need to implement several key strategies — and technology is a key component to making everything easier on all organizations. The post Remote Patient Monitoring Works … What are Payers and Providers Waiting for? appeared first on MedCity News.
The best healthcare technology emerges from collaborative efforts. Here’s why working alongside physicians, nurses, and home health caregivers builds a stronger foundation. The post Centering Caregiver and Provider Feedback in Home-Based Care Innovation appeared first on MedCity News.
The PTC Therapeutics gene therapy, Kebilidi, treats an enzyme deficiency that affects the body’s ability to produce dopamine, a neurotransmitter important for motor control. FDA approval for the product comes two years after it won its first regulatory approvals in Europe. The post PTC Therapeutics Wins First FDA Approval for a Gene Therapy Dosed Directly…